BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7131298)

  • 1. Selective effects of phenylethylamine on central catecholamines: a comparative study with amphetamine.
    Karoum F; Speciale SG; Chuang LW; Wyatt RJ
    J Pharmacol Exp Ther; 1982 Nov; 223(2):432-9. PubMed ID: 7131298
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of (-) deprenyl on monoamine turnover rate in rat brain.
    Zsilla G; Knoll J
    Adv Biochem Psychopharmacol; 1982; 31():211-7. PubMed ID: 6805258
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence and distribution of phenylethylamine in the rat spinal cord.
    Karoum F; Chuang LW; Wyatt RJ
    Brain Res; 1981 Nov; 225(2):442-5. PubMed ID: 7306800
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic treatment with central stimulants on brain monoamines and some behavioral and physiological functions in rats, guinea pigs, and rabbits.
    Lewander T
    Adv Biochem Psychopharmacol; 1974; 12(0):221-39. PubMed ID: 4607740
    [No Abstract]   [Full Text] [Related]  

  • 5. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of central actions of intraventricularly administered octopamine, phenylethylamine and adrenaline in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1983; 35(1):59-62. PubMed ID: 6412221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally defined adrenergic agents. II. The effect of endo- and exo-2-aminobenzobicyclo-[2.2.2] octene, conformationally defined amphetamine analogs, on the uptake and release of central catecholamines.
    Bartholow RM; Eiden LE; Ruth JA; Grunewald GL; Siebert J; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):532-43. PubMed ID: 894520
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lithium on behaviour and central monoamines.
    Engel J; Berggren U
    Acta Psychiatr Scand Suppl; 1980; 280():133-43. PubMed ID: 6773300
    [No Abstract]   [Full Text] [Related]  

  • 9. Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.
    Mogilnicka E; Braestrup C
    J Pharm Pharmacol; 1976 Mar; 28(3):253-5. PubMed ID: 6705
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Responses of cortical pyramidal tract cells to amantadine and amphetamine after depletion of central catecholamines.
    Stone TW
    Br J Pharmacol; 1975 Jun; 54(2):244P-245P. PubMed ID: 1148533
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavior and brain contents of catecholamines in mice during chronic administration of methyldopa.
    Dominic JA; Moore KE
    Neuropharmacology; 1971 Sep; 10(5):565-70. PubMed ID: 4399541
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the functional roles of norepinephrine, dopamine, and phenylethylamine in the central nervous system.
    Sabelli HC; Giardina WJ; Mosnaim AD; Sabelli NH
    Acta Physiol Pol; 1973; 24(1):33-40. PubMed ID: 4716347
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine.
    Chuang LW; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1982 Jul; 81(3):385-92. PubMed ID: 7117382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta -phenylethylamine on behavior and polyribosomes in the rat.
    Widelitz MM
    Biochem Biophys Res Commun; 1979 Jan; 86(1):48-56. PubMed ID: 435304
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine induced stereotyped behaviour correlated with the accumulation of O-methylated dopamine.
    Jonas W; Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):379-89. PubMed ID: 5807174
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenylethylamine, norepinephrine and mounting behavior in the male rat.
    Segal M; Shohami E; Jacobowitz DM
    Pharmacol Biochem Behav; 1984 Jan; 20(1):133-5. PubMed ID: 6694992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Br J Pharmacol; 1972 May; 45(1):165P-166P. PubMed ID: 5041482
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the relation of endogenous norepinephrine to phenylethylamine analog-induced antinociception.
    Matsuoka Y; Sakuma M; Sugioka T; Terawaki Y; Uruno T; Kubota K
    Jpn J Pharmacol; 1988 Oct; 48(2):263-72. PubMed ID: 3210449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of beta-phenylethylamine on central and peripheral monoamine-containing neurons.
    Fuxe K; Grobecker H; Jonsson J
    Eur J Pharmacol; 1967 Dec; 2(3):202-7. PubMed ID: 5590344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.